Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
ChromaDex Corporation, a leading player in the nutraceutical and dietary supplement industry, is headquartered in the United States. Founded in 2009, the company has established itself as a pioneer in the development and commercialisation of innovative ingredients and products that support health and wellness.
ChromaDex is renowned for its flagship product, TRU Niagen®, a patented form of nicotinamide riboside that promotes cellular health and energy metabolism. This unique offering has positioned the company at the forefront of the burgeoning market for NAD+ precursors, appealing to health-conscious consumers and researchers alike.
With a commitment to scientific research and quality, ChromaDex has achieved significant milestones, including partnerships with major brands and recognition for its contributions to the field of nutritional science. As it continues to expand its operational reach, ChromaDex remains dedicated to enhancing the understanding of cellular health and the role of dietary supplements in overall well-being.
-19 vs industry average
ChromaDex’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for ChromaDex yet.
ChromaDex, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. This lack of data suggests that ChromaDex may not have established formal commitments to reduce its carbon footprint or may not publicly disclose such information.
In the context of industry standards, companies are increasingly expected to set science-based targets and report on their emissions across Scope 1, 2, and 3 categories. However, without specific data or commitments from ChromaDex, it is unclear how the company aligns with these expectations. As the climate landscape evolves, it will be important for ChromaDex to consider establishing measurable targets and transparent reporting to enhance its sustainability profile.
No climate goals have been disclosed for ChromaDex yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more